• Home
  • Search Results
  • Plasma phospholipids identify antecedent memory impairment in older adults.

Plasma phospholipids identify antecedent memory impairment in older adults.

Nature medicine (2014-03-13)
Mark Mapstone, Amrita K Cheema, Massimo S Fiandaca, Xiaogang Zhong, Timothy R Mhyre, Linda H MacArthur, William J Hall, Susan G Fisher, Derick R Peterson, James M Haley, Michael D Nazar, Steven A Rich, Dan J Berlau, Carrie B Peltz, Ming T Tan, Claudia H Kawas, Howard J Federoff
ABSTRACT

Alzheimer's disease causes a progressive dementia that currently affects over 35 million individuals worldwide and is expected to affect 115 million by 2050 (ref. 1). There are no cures or disease-modifying therapies, and this may be due to our inability to detect the disease before it has progressed to produce evident memory loss and functional decline. Biomarkers of preclinical disease will be critical to the development of disease-modifying or even preventative therapies. Unfortunately, current biomarkers for early disease, including cerebrospinal fluid tau and amyloid-β levels, structural and functional magnetic resonance imaging and the recent use of brain amyloid imaging or inflammaging, are limited because they are either invasive, time-consuming or expensive. Blood-based biomarkers may be a more attractive option, but none can currently detect preclinical Alzheimer's disease with the required sensitivity and specificity. Herein, we describe our lipidomic approach to detecting preclinical Alzheimer's disease in a group of cognitively normal older adults. We discovered and validated a set of ten lipids from peripheral blood that predicted phenoconversion to either amnestic mild cognitive impairment or Alzheimer's disease within a 2-3 year timeframe with over 90% accuracy. This biomarker panel, reflecting cell membrane integrity, may be sensitive to early neurodegeneration of preclinical Alzheimer's disease.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
L-Proline, ReagentPlus®, ≥99% (HPLC)
Sigma-Aldrich
L-Proline, from non-animal source, meets EP, USP testing specifications, suitable for cell culture
Sigma-Aldrich
L-Asparagine, ≥98% (HPLC)
Sigma-Aldrich
L-Asparagine, BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
L-Carnitine inner salt, synthetic, ≥98%
SAFC
L-Proline, PharmaGrade, Ajinomoto, EP, JP, USP, Manufactured under appropriate GMP controls for pharma or biopharmaceutical production, suitable for cell culture
Sigma-Aldrich
DL-Malic acid, ReagentPlus®, ≥99%
Sigma-Aldrich
Ursodeoxycholic acid, ≥99%
Sigma-Aldrich
L-Proline, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
DL-Malic acid, ≥98% (capillary GC)
Supelco
Malic acid, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
L-Proline, 99%, FCC, FG
Sigma-Aldrich
DL-Malic acid, 99%
Supelco
L-Proline, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
D-(+)-Malic acid, unnatural form, ≥97.0% (T)
Sigma-Aldrich
Malic acid, meets USP/NF testing specifications
Supelco
DL-Malic acid, analytical standard
Sigma-Aldrich
Glycoursodeoxycholic acid, ≥96.0% (TLC)
Supelco
L-Asparagine, certified reference material, TraceCERT®
Sigma-Aldrich
DL-Malic acid disodium salt, ≥95% (capillary GC)
Proline, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
L-(−)-Malic acid disodium salt, 95-100% (enzymatic)
USP
L-Proline, United States Pharmacopeia (USP) Reference Standard
Supelco
L-Proline, certified reference material, TraceCERT®
Sigma-Aldrich
DL-Malic acid, meets analytical specification of FCC, E296, 99-100.5% (alkalimetric)
USP
Levocarnitine, United States Pharmacopeia (USP) Reference Standard
Ursodeoxycholic acid for system suitability, European Pharmacopoeia (EP) Reference Standard
Ursodeoxycholic acid, European Pharmacopoeia (EP) Reference Standard
Levocarnitine, European Pharmacopoeia (EP) Reference Standard
USP
Ursodiol, United States Pharmacopeia (USP) Reference Standard

Social Media

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

MilliporeSigma

Research. Development. Production.

We are a leading supplier to the global Life Science industry with solutions and services for research, biotechnology development and production, and pharmaceutical drug therapy development and production.

© 2021 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

Reproduction of any materials from the site is strictly forbidden without permission.